search
Back to results

Assessing Parathyroid Glands Vascularisation by ICG Fluoroscopy

Primary Purpose

Parathyroid Function Low Adverse Event

Status
Completed
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
Postoperative parathyroid function test
No postoperative parathyroid dosage and supplementation
ICG parathyroid angiography
Parathyroid supplementation
Sponsored by
University Hospital, Geneva
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Parathyroid Function Low Adverse Event focused on measuring Parathyroid gland angiography, Parathyroid gland indocyanine green angiography, Parathyroid gland indocyanine green fluoroscopy

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adult patients undergoing total thyroidectomy or a totalisation thyroid procedure.
  • Patients capable of understanding and able to understand the study.
  • Values visually 2 and ICG 2

Exclusion Criteria:

  • Parathyroid disease or prior parathyroidectomy
  • Lack of informed consent
  • Altered mental status of the patient.
  • ICG values <2.

Sites / Locations

  • University Hospitals Geneva

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

New treatment

Standart treatment

Arm Description

In patients with at least one well perfused parathyroid gland on ICG parathyroid angiography, no postoperative parathyroid dosage and supplementation will be done. Calcium and parathormone dosage will be done 10 days after surgery.

In those patients in whom at least on of the four parathyroid glands is well perused, postoperative parathyroid function test and parathyroid supplementation will be done. Calcium and parathormone dosage will be done at 24 hours and 10 days after surgery. Prophylactic supplementation of calcium and Vitamin D will be given.

Outcomes

Primary Outcome Measures

Postoperative parathyroid function
All patients will be reviewed at 10-15 days after surgery and blood tests will be done. Investigators will check the number of patients with serum calcium and parathyroid hormone in normal ranges at ten days after surgery in both arms of the study. Low parathyroid function will be diagnosed when corrected calcium < 2mmol/l, and PTH < 1.1 pmol/l.

Secondary Outcome Measures

Calcium and parathormone dosage after surgery
Number of patients with good calcium and parathormone values at 10 days after surgery without calcium and vitamin D supplementation in the selected group.

Full Information

First Posted
September 15, 2014
Last Updated
April 15, 2016
Sponsor
University Hospital, Geneva
Collaborators
Geneva University, School of medicine
search

1. Study Identification

Unique Protocol Identification Number
NCT02249780
Brief Title
Assessing Parathyroid Glands Vascularisation by ICG Fluoroscopy
Official Title
The Use of Indocyanine Green Fluorescence to Assses the Vascularisation of the Parathyroid Glands During Thyroid Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
September 2014
Overall Recruitment Status
Completed
Study Start Date
September 2014 (undefined)
Primary Completion Date
February 2016 (Actual)
Study Completion Date
February 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University Hospital, Geneva
Collaborators
Geneva University, School of medicine

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Evaluate parathyroid gland perfusion during total thyroidectomy or thyroid totalisation surgery. Create an objective basis for the decision whether or not to transplant the parathyroid glands. Avoide postoperative serum calcium and parathyroid hormone dosages, and thus abstention of systematic supplementation with calcium and vitamin D in case of good perfusion.
Detailed Description
Parathyroid intraoperative indocyanine green (ICG) angiography is a new concept. To simplify the procedure the investigators have classified images into three categories: ICG 2: good blood supply (the gland has a white color); ICG 1: traumatic gland (the gland has a grayish color) and ICG 0: the gland is not vascularized (she has a black color). The investigators have applied the same criteria for visual values. The investigators will randomize 138 patients with good ICG test values (at least one gland that is visually ≥1 and ICG 2): 69 will be subject to the usual postoperative care in the investigators service: 24 hours monitoring with dosage of calcium and PTH in the morning on postoperative day 1 and routine supplementation with Calcimagon D3 Forte (1g Calcium and 800 IU of 25-OH-vitamin D) BD by mouth until postoperative follow-up appointment, which takes place between day 10 and 15. Depending on the results of blood tests patients will also be given Rocaltrol substitution (1, 25-OH-Vitamin D) 0.5mcg BD. The remaining patients will be monitored 24 hours in hospital looking for clinical signs and symptoms of hypocalcemia but without any blood dosage or systematic supplementation. If signs and / or symptoms of hypocalcemia develop (tingling, muscle spasms, Chvostek sign), a blood test will be performed and patients will be substituted by the usual protocol. All patients will be reviewed at 10 - 15 days of the intervention with the relevant balance sheet.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Parathyroid Function Low Adverse Event
Keywords
Parathyroid gland angiography, Parathyroid gland indocyanine green angiography, Parathyroid gland indocyanine green fluoroscopy

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
146 (Actual)

8. Arms, Groups, and Interventions

Arm Title
New treatment
Arm Type
Experimental
Arm Description
In patients with at least one well perfused parathyroid gland on ICG parathyroid angiography, no postoperative parathyroid dosage and supplementation will be done. Calcium and parathormone dosage will be done 10 days after surgery.
Arm Title
Standart treatment
Arm Type
Active Comparator
Arm Description
In those patients in whom at least on of the four parathyroid glands is well perused, postoperative parathyroid function test and parathyroid supplementation will be done. Calcium and parathormone dosage will be done at 24 hours and 10 days after surgery. Prophylactic supplementation of calcium and Vitamin D will be given.
Intervention Type
Procedure
Intervention Name(s)
Postoperative parathyroid function test
Intervention Description
Calcium and parathormone dosage at 24 hours and ten day after surgery
Intervention Type
Procedure
Intervention Name(s)
No postoperative parathyroid dosage and supplementation
Other Intervention Name(s)
Parathiroid function testing
Intervention Description
The patients will be clinically followed for 24 hours after surgery and caclium and parathormone dosage will be done at ten days after surgery. No supplementation will be given.
Intervention Type
Procedure
Intervention Name(s)
ICG parathyroid angiography
Other Intervention Name(s)
Indoyanine green angiography, Indoyanine green fluoroscopy
Intervention Description
Injection of 3,5 mL of indocyanine green intravenously and perform angiography of parathyroid glands after thyroid removal.
Intervention Type
Drug
Intervention Name(s)
Parathyroid supplementation
Other Intervention Name(s)
Hypocalcemia post thyroidectomy treatment
Intervention Description
Supplementration with Calcimagon D3 Forte (1gr Calcium and 800 IU of 25-OH-vitamin D) from surgery day to up to 10 days afeter surgery.
Primary Outcome Measure Information:
Title
Postoperative parathyroid function
Description
All patients will be reviewed at 10-15 days after surgery and blood tests will be done. Investigators will check the number of patients with serum calcium and parathyroid hormone in normal ranges at ten days after surgery in both arms of the study. Low parathyroid function will be diagnosed when corrected calcium < 2mmol/l, and PTH < 1.1 pmol/l.
Time Frame
10 days after surgery
Secondary Outcome Measure Information:
Title
Calcium and parathormone dosage after surgery
Description
Number of patients with good calcium and parathormone values at 10 days after surgery without calcium and vitamin D supplementation in the selected group.
Time Frame
10 days after surgery
Other Pre-specified Outcome Measures:
Title
Economic impact
Description
Compare the costs of both procedures: standard procedure and new treatment and then evaluate the economic impact of this preventig mesure, and the possibility to undergo ambulatory surgery
Time Frame
From surgery day to 10 days after surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adult patients undergoing total thyroidectomy or a totalisation thyroid procedure. Patients capable of understanding and able to understand the study. Values visually 2 and ICG 2 Exclusion Criteria: Parathyroid disease or prior parathyroidectomy Lack of informed consent Altered mental status of the patient. ICG values <2.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Frédéric Triponez, Professor
Organizational Affiliation
University Hospital, Geneva
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Wolfram Karenovics, SPR
Organizational Affiliation
University Hospital, Geneva
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Frédéric Ris, Consultant
Organizational Affiliation
University Hospital, Geneva
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Valentina Belfontali, Resident
Organizational Affiliation
University Hospital, Geneva
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jordi Vidal Fortuny, SPR
Organizational Affiliation
University Hospital, Geneva
Official's Role
Study Chair
Facility Information:
Facility Name
University Hospitals Geneva
City
Geneva
ZIP/Postal Code
1205
Country
Switzerland

12. IPD Sharing Statement

Citations:
PubMed Identifier
29405252
Citation
Vidal Fortuny J, Sadowski SM, Belfontali V, Guigard S, Poncet A, Ris F, Karenovics W, Triponez F. Randomized clinical trial of intraoperative parathyroid gland angiography with indocyanine green fluorescence predicting parathyroid function after thyroid surgery. Br J Surg. 2018 Mar;105(4):350-357. doi: 10.1002/bjs.10783. Epub 2018 Feb 6.
Results Reference
derived

Learn more about this trial

Assessing Parathyroid Glands Vascularisation by ICG Fluoroscopy

We'll reach out to this number within 24 hrs